Richard J. Chappell

Generating author description...

All published works

Action	Title	Year	Authors
+	Comparison of sample characteristics of Wisconsin Alzheimer's Disease Research Center participants with the Wisconsin state population—An evaluation of the recruitment effort	2025	Yue Ma Maria Mora Pinzón William R. Buckingham Andrew J. Bersch W. Ryan Powell Tamara J. LeCaire Gilda E. Ennis Yuetiva Deming Erin M. Jonaitis Nathaniel A. Chin
+ PDF Chat	Longitudinal normative standards for cognitive tests and composites using harmonized data from two Wisconsin AD‐risk‐enriched cohorts	2024	Erin M. Jonaitis Bruce P. Hermann Kimberly D. Mueller Lindsay R. Clark Lianlian Du Tobey J. Betthauser Karly Alex Cody Carey E. Gleason Bradley T. Christian Sanjay Asthana
+ PDF Chat	A study on the sample representativeness of the Wisconsin Alzheimer’s Disease Research Center Clinical Core participants versus the Wisconsin state population	2023	Yue Ma Maria Mora Pinzón William R. Buckingham Andrew J. Bersch W. Ryan Powell Tamara J. LeCaire Gilda E. Ennis Yuetiva Deming Erin M. Jonaitis Leah Reuter
+	Designing superiority trials with window mean survival time as a primary endpoint	2023	Mitchell Paukner Richard J. Chappell
+ PDF Chat	Log-Rank Test vs MaxCombo and Difference in Restricted Mean Survival Time Tests for Comparing Survival Under Nonproportional Hazards in Immuno-oncology Trials	2022	Pralay Mukhopadhyay Jiabu Ye Keaven M. Anderson Satrajit Roychoudhury Eric H. Rubin Susan Halabi Richard J. Chappell
+	Window mean survival time	2021	Mitchell Paukner Richard J. Chappell
+	Comparison of survival distributions in clinical trials: A practical guidance	2020	Xiaotian Chen Xin Wang Kun Chen Yeya Zheng Richard J. Chappell Jyotirmoy Dey
+ PDF Chat	Tests for equivalence of two survival functions: Alternative to the tests under proportional hazards	2014	Elvis E Martinez Debajyoti Sinha Wenting Wang Stuart R. Lipsitz Richard J. Chappell
+ PDF Chat	Advanced colorectal neoplasia risk stratification by penalized logistic regression	2013	Yunzhi Lin Menggang Yu Sijian Wang Richard J. Chappell Thomas F. Imperiale
+ PDF Chat	A systematic selection method for the development of cancer staging systems	2013	Yunzhi Lin Richard J. Chappell Mithat Gönen
+ PDF Chat	Lasso tree for cancer staging with survival data	2012	Yunzhi Lin Sijian Wang Richard J. Chappell
+ PDF Chat	Statistics in Oncology	2008	Stephanie R. Land Judith Abrams Marc Buyse Richard J. Chappell
+	A Multi-Institutional Phase I/II Trial of Dose-per-fraction Escalation for Localized Prostate Cancer	2005	M.A. Ritter Richard J. Chappell Wolfgang A. Tomé Patrick A. Kupelian
+	Semiparametric Methods for Semi-competing Risks Problem with Censoring and Truncation	2004	Hongyu Jiang Jason P. Fine Richard J. Chappell

Common Coauthors

Coauthor	Papers Together
Carey E. Gleason	3
Sanjay Asthana	3
Yunzhi Lin	3
Nathaniel A. Chin	3
Erin M. Jonaitis	3
Mitchell Paukner	2
Yue Ma	2
Barbara B. Bendlin	2
W. Ryan Powell	2
Sijian Wang	2
Andrew J. Bersch	2
Dorothy Farrar Edwards	2
Art Walaszek	2
Maria Mora Pinzón	2
Yuetiva Deming	2
Tamara J. LeCaire	2
Amy Kind	2
Sterling C. Johnson	2
Cynthia M. Carlsson	2
Gilda E. Ennis	2
Ozioma C. Okonkwo	2
Lindsay R. Clark	2
William R. Buckingham	2
Alice Spalitta	1
M.A. Ritter	1
Mithat Gönen	1
Bradley T. Christian	1
Susan Halabi	1
Kimberly D. Mueller	1
Menggang Yu	1
Thomas F. Imperiale	1
Elvis E Martinez	1
Pralay Mukhopadhyay	1
Bruce P. Hermann	1
Stephanie R. Land	1
Xin Wang	1
Eric H. Rubin	1
Megan Zuelsdorff	1
Stuart R. Lipsitz	1
Keaven M. Anderson	1
Rebecca E Langhough	1
Marc Buyse	1
Sterling C. Johnson	1
Debajyoti Sinha	1
Leah Reuter	1
William B. Bevis	1
Wenting Wang	1
Judith Abrams	1
Michelle L. Wahoske	1
Kun Chen	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+ PDF Chat	Methods for Accommodating Nonproportional Hazards in Clinical Trials: Ready for the Primary Analysis?	2019	Boris Freidlin Edward L. Korn	4
+ PDF Chat	Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome	2013	Patrick Royston Mahesh Parmar	3
+ PDF Chat	A versatile test for equality of two survival functions based on weighted differences of Kaplan–Meier curves	2015	Hajime Uno Lü Tian Brian Claggett L. J. Wei	3
+ PDF Chat	Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis	2014	Hajime Uno Brian Claggett Lü Tian Eisuke Inoue Paul Gallo Toshio Miyata Deborah Schrag Masahiro Takeuchi Yoshiaki Uyama Lihui Zhao	3
+	The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt	2011	Patrick Royston Mahesh Parmar	2
+ PDF Chat	Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?	2017	Everardo D. Saad John Zalcberg Julien Péron Elisabeth Coart Tomasz Burzykowski Marc Buyse	2
+ PDF Chat	Estimating the Dimension of a Model	1978	Gideon Schwarz	2
+	A class of rank test procedures for censored survival data	1982	David P. Harrington Thomas R. Fleming	2
+ PDF Chat	The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials	2016	Julien Péron Pascal Roy Brice Ozenne Laurent Roche Marc Buyse	2
+	On the versatility of the combination of the weighted log-rank statistics	2007	Seung-Hwan Lee	2
+	Efficiency of Two Sample Tests via the Restricted Mean Survival Time for Analyzing Event Time Observations	2017	Lü Tian Haoda Fu Stephen J. Ruberg Hajime Uno L. J. Wei	2
+ PDF Chat	Sparsity and Smoothness Via the Fused Lasso	2004	Robert Tibshirani Michael A. Saunders Saharon Rosset Ji Zhu Keith Knight	2
+	A Two-Sample Censored-Data Rank Test for Acceleration	1984	N. E. Breslow Lutz Edler J. Berger	2
+ PDF Chat	Statistical and practical considerations in designing of immuno-oncology trials	2020	Pralay Mukhopadhyay Wenmei Huang Paul Metcalfe Fredrik Öhrn Mary Jenner Andrew Stone	2
+	Heuristics of instability and stabilization in model selection	1996	Leo Breiman	2
+	Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials	2016	Ludovic Trinquart Justine Jacot Sarah C. Conner Raphaël Porcher	2
+ PDF Chat	Weighted Kaplan-Meier Statistics: A Class of Distance Tests for Censored Survival Data	1989	Margaret S. Pepe Thomas R. Fleming	2
+ PDF Chat	Modestly weighted logrank tests	2019	Dominic Magirr Carl‐Fredrik Burman	2
+	Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model	2000	Colin B. Begg Laura D. Cramer Ennapadam Venkatraman Juan Rosaí	2
+ PDF Chat	Variable Selection for Cox's proportional Hazards Model and Frailty Model	2002	Jianqing Fan Runze Li	2
+	Equivalence of two treatments and sample size determination under exponential survival model with censoring	2004	Jun‐mo Nam Jinheum Kim Seungyeoun Lee	1
+	Generalized pairwise comparisons of prioritized outcomes in the two‐sample problem	2010	Marc Buyse	1
+	The Hazards of Hazard Ratios	2009	Miguel A. Hernán	1
+	Regression analysis for long-term survival rate	1996	Seung‐Hyun Jung	1
+ PDF Chat	Generalized Maximally Selected Statistics	2008	Torsten Hothorn Achim Zeileis	1
+	Assessment and comparison of prognostic classification schemes for survival data	1999	Erika Graf Claudia Schmoor Willi Sauerbrei M. Schumacher	1
+	EXPLAINED VARIATION IN SURVIVAL ANALYSIS	1996	M. Schemper Janez Stare	1
+ PDF Chat	Least angle regression	2004	Bradley Efron Trevor Hastie Iain M. Johnstone Robert Tibshirani	1
+	On the Distribution of the Maximum of the Logrank Statistic and the Modified Wilcoxon Statistic	1981	Robert E. Tarone	1
+ PDF Chat	Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker	2004	M. S. Pepe	1
+	TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS	1996	Kerry L. Lee Daniel B. Mark	1
+	Combining asymptotically normal tests: case studies in comparison of two groups	2004	Song Yang Li Hsu Lueping Zhao	1
+	Linear rank tests with right censored data	1978	Ross L. Prentice	1
+ PDF Chat	Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies	2015	Hajime Uno Janet Wittes Haoda Fu Scott D. Solomon Brian Claggett Lü Tian Tianxi Cai Marc A. Pfeffer Scott Evans L. J. Wei	1
+	Restricted Mean Life with Covariates: Modification and Extension of a Useful Survival Analysis Method	1998	David M. Zucker	1
+	Maximum Likelihood Estimation in the Proportional Odds Model	1997	Susan A. Murphy Anthony Rossini Aad van der Vaart	1
+ PDF Chat	Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves	2012	Patricia Guyot A. E. Ades Mario JNM Ouwens Nicky J. Welton	1
+	The Statistics of Dimers on a Lattice	2009	Piet Kasteleyn	1
+	The Robust Inference for the Cox Proportional Hazards Model	1989	D. Y. Lin L. J. Wei	1
+ PDF Chat	Properties and refinements of the fused lasso	2009	Alessandro Rinaldo	1
+	Evaluating the effect of optimized cutoff values in the assessment of prognostic factors	1996	Berthold Lausen Martin Schumacher	1
+	Quantile Regression	2005	Roger Koenker	1
+	AN ASYMPTOTIC THEORY FOR LINEAR MODEL SELECTION	1997	Jun Shao	1
+ PDF Chat	A systematic selection method for the development of cancer staging systems	2013	Yunzhi Lin Richard J. Chappell Mithat Gönen	1
+ PDF Chat	A Measure of Explained Variation for Event History Data	2010	Janez Stare Maja Pohar Perme Robin Henderson	1
+ PDF Chat	Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study	2012	Lihui Zhao Lü Tian Hajime Uno Scott D. Solomon Marc A. Pfeffer Jerald Schindler Lee Jen Wei	1
+ PDF Chat	Selection Bias Due to Loss to Follow Up in Cohort Studies	2015	Chanelle J. Howe Stephen R. Cole Bryan Lau Sonia Napravnik Joseph J. Eron	1
+	Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing	1995	Yoav Benjamini Yosef Hochberg	1
+	Counting Processes and Survival Analysis	2007	Shin Ta Liu	1
+	Influence of Unrecognized Molecular Heterogeneity on Randomized Clinical Trials	2002	Rebecca A. Betensky David N. Louis J. Gregory Cairncross	1